Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup

• M. Chehani Alles ,

  Contributed equally to this work with: M. Chehani Alles, Margaret Gardiner-Garden

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia

  ⨯
• Margaret Gardiner-Garden ,

  Contributed equally to this work with: M. Chehani Alles, Margaret Gardiner-Garden

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia

  ⨯
• David J. Nott,

  Affiliation Department of Statistics and Applied Probability, National University of Singapore, Singapore, Singapore

  ⨯
• Yixin Wang,

  Affiliation Veridex LLC, a Johnson & Johnson Company, North Raritan, New Jersey, United States of America

  ⨯
• John A. Foekens,

  Affiliation Erasmus MC Rotterdam, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Rotterdam, the Netherlands

  ⨯
• Robert L. Sutherland,

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia

  ⨯
• Elizabeth A. Musgrove,

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia

  ⨯
• Christopher J. Ormandy

  * E-mail: c.ormandy@garvan.org.au

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia

  ⨯